Physician profile
Mark Padilla
NPI 1043615495
$3,700.17
in general payments reported to CMS, 2019-2025
12 companies · $649 in 2025
The $649 reported for 2025 was more than what 84% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,600 · 2020: $57.02 · 2021: $81.86 · 2022: $136 · 2023: $582 · 2024: $595 · 2025: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,816 · Gift: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,815.50 |
| Gift | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ormco Corporation | $1,900.20 | 2019-2023 | Spark |
| Envista Holdings Corporation | $739.16 | 2024-2025 | Spark, Damon 3, Synthesis |
| Dental Monitoring Sas | $287.09 | 2025 | |
| Nobel Biocare USA | $272.56 | 2023 | Nobelactive |
| Forestadent USA, INC. | $217.77 | 2019-2025 | |
| World Class Technology Corporation | $121.13 | 2019-2025 | Pitts21, Pitts21 Pro |
| Gc America INC. | $81.23 | 2020-2022 | |
| Ortho Organizers, INC. | $30.50 | 2022 | |
| Align Technology, INC. | $16.72 | 2025 | Invisalign |
| Dentsply Sirona INC | $12.14 | 2019 | |
| Dentsply Sirona Orthodontics INC | $11.67 | 2019 | |
| Purelife, LLC | $10.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Padilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.